ID   MMG3
AC   CVCL_H729
SY   MMG-3
DR   cancercelllines; CVCL_H729
DR   CGH-DB; 9283-4
DR   Cosmic; 905197
DR   Wikidata; Q54906220
RX   PubMed=15160996;
RX   PubMed=15467732;
CC   From: Department of Dermatology, Gifu University; Gifu; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
RX   PubMed=15160996;
RA   Akiyama Y., Maruyama K., Nara N., Mochizuki T., Yamamoto A.,
RA   Yamazaki N., Kawashima I., Nukaya I., Takesako K., Yamaguchi K.;
RT   "Cytotoxic T cell induction against human malignant melanoma cells
RT   using HLA-A24-restricted melanoma peptide cocktail.";
RL   Anticancer Res. 24:571-577(2004).
//
RX   PubMed=15467732; DOI=10.1038/sj.onc.1208152;
RA   Tanami H., Imoto I., Hirasawa A., Yuki Y., Sonoda I., Inoue J.,
RA   Yasui K., Misawa-Furihata A., Kawakami Y., Inazawa J.;
RT   "Involvement of overexpressed wild-type BRAF in the growth of
RT   malignant melanoma cell lines.";
RL   Oncogene 23:8796-8804(2004).
//